Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. Its Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.
52 Week high
52 Week low
Zacks Investment Research • 2 days ago • EWITGR or EW: Which Is the Better Value Stock Right Now?
Zacks Investment Research • 10 days ago • EWHere's Why You Should Invest in Edward Lifesciences (EW) Now
Zacks Investment Research • 18 days ago • EWITGR vs. EW: Which Stock Is the Better Value Option?
InvestorPlace • 24 days ago • EWBeyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains
PRNewsWire • 25 days ago • EWBetterInvesting™ Magazine Update on Edwards Lifesciences Corp. and 3M Company
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.